The AZITROCIN brand, founded in 2002 (United States), from
1125 sister brands
and 17477 competing brands.
The AZITROCIN brand is owned by Pfizer Inc, a company listed in New York.
AZITROCIN is part of the Drug Manufacturers activity sector.
Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.